Logo image of DIM.PA

SARTORIUS STEDIM BIOTECH (DIM.PA) Stock Fundamental Analysis

EPA:DIM - FR0013154002 - Common Stock

170.95 EUR
-3.3 (-1.89%)
Last: 9/4/2025, 7:00:00 PM
Fundamental Rating

5

Overall DIM gets a fundamental rating of 5 out of 10. We evaluated DIM against 18 industry peers in the Life Sciences Tools & Services industry. DIM has only an average score on both its financial health and profitability. DIM is valued quite expensively, but it does show have an excellent growth rating. This makes DIM very considerable for growth investing!


Dividend Valuation Growth Profitability Health

Quickly go to:

5

1. Profitability

1.1 Basic Checks

DIM had positive earnings in the past year.
In the past year DIM had a positive cash flow from operations.
Each year in the past 5 years DIM has been profitable.
Each year in the past 5 years DIM had a positive operating cash flow.
DIM.PA Yearly Net Income VS EBIT VS OCF VS FCFDIM.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

1.2 Ratios

DIM has a Return On Assets (2.71%) which is comparable to the rest of the industry.
DIM has a Return On Equity (5.63%) which is comparable to the rest of the industry.
DIM has a Return On Invested Capital (4.60%) which is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for DIM is above the industry average of 7.23%.
The 3 year average ROIC (10.41%) for DIM is well above the current ROIC(4.60%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 2.71%
ROE 5.63%
ROIC 4.6%
ROA(3y)7.81%
ROA(5y)9.13%
ROE(3y)17.3%
ROE(5y)20.06%
ROIC(3y)10.41%
ROIC(5y)14.57%
DIM.PA Yearly ROA, ROE, ROICDIM.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

Looking at the Profit Margin, with a value of 7.78%, DIM is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
In the last couple of years the Profit Margin of DIM has declined.
DIM has a Operating Margin (14.71%) which is comparable to the rest of the industry.
DIM's Operating Margin has declined in the last couple of years.
DIM has a better Gross Margin (44.63%) than 72.22% of its industry peers.
DIM's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 14.71%
PM (TTM) 7.78%
GM 44.63%
OM growth 3Y-22.38%
OM growth 5Y-9.98%
PM growth 3Y-24.01%
PM growth 5Y-17.3%
GM growth 3Y-6.9%
GM growth 5Y-3.53%
DIM.PA Yearly Profit, Operating, Gross MarginsDIM.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

More info and screens

5

2. Health

2.1 Basic Checks

DIM has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
DIM has more shares outstanding than it did 1 year ago.
The number of shares outstanding for DIM has been increased compared to 5 years ago.
Compared to 1 year ago, DIM has an improved debt to assets ratio.
DIM.PA Yearly Shares OutstandingDIM.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
DIM.PA Yearly Total Debt VS Total AssetsDIM.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

DIM has an Altman-Z score of 3.68. This indicates that DIM is financially healthy and has little risk of bankruptcy at the moment.
DIM has a Altman-Z score of 3.68. This is in the better half of the industry: DIM outperforms 72.22% of its industry peers.
The Debt to FCF ratio of DIM is 5.98, which is a neutral value as it means it would take DIM, 5.98 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of DIM (5.98) is comparable to the rest of the industry.
DIM has a Debt/Equity ratio of 0.71. This is a neutral value indicating DIM is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.71, DIM is in line with its industry, outperforming 44.44% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF 5.98
Altman-Z 3.68
ROIC/WACC0.54
WACC8.46%
DIM.PA Yearly LT Debt VS Equity VS FCFDIM.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.3 Liquidity

A Current Ratio of 1.91 indicates that DIM should not have too much problems paying its short term obligations.
With an excellent Current ratio value of 1.91, DIM belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
DIM has a Quick Ratio of 1.18. This is a normal value and indicates that DIM is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.18, DIM perfoms like the industry average, outperforming 44.44% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.91
Quick Ratio 1.18
DIM.PA Yearly Current Assets VS Current LiabilitesDIM.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 25.91% over the past year.
Measured over the past 5 years, DIM shows a small growth in Earnings Per Share. The EPS has been growing by 4.19% on average per year.
Looking at the last year, DIM shows a small growth in Revenue. The Revenue has grown by 5.44% in the last year.
Measured over the past years, DIM shows a quite strong growth in Revenue. The Revenue has been growing by 14.05% on average per year.
EPS 1Y (TTM)25.91%
EPS 3Y-22.3%
EPS 5Y4.19%
EPS Q2Q%38.82%
Revenue 1Y (TTM)5.44%
Revenue growth 3Y-1.25%
Revenue growth 5Y14.05%
Sales Q2Q%5.46%

3.2 Future

DIM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.31% yearly.
Based on estimates for the next years, DIM will show a quite strong growth in Revenue. The Revenue will grow by 10.52% on average per year.
EPS Next Y27.61%
EPS Next 2Y23.83%
EPS Next 3Y23.3%
EPS Next 5Y22.31%
Revenue Next Year9.1%
Revenue Next 2Y9.69%
Revenue Next 3Y10.4%
Revenue Next 5Y10.52%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
DIM.PA Yearly Revenue VS EstimatesDIM.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B
DIM.PA Yearly EPS VS EstimatesDIM.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6 8 10

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 41.39, the valuation of DIM can be described as expensive.
Based on the Price/Earnings ratio, DIM is valued a bit more expensive than 66.67% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.03, DIM is valued quite expensively.
With a Price/Forward Earnings ratio of 31.85, DIM can be considered very expensive at the moment.
DIM's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. DIM is more expensive than 66.67% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.63, DIM is valued a bit more expensive.
Industry RankSector Rank
PE 41.39
Fwd PE 31.85
DIM.PA Price Earnings VS Forward Price EarningsDIM.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DIM indicates a slightly more expensive valuation: DIM is more expensive than 72.22% of the companies listed in the same industry.
The rest of the industry has a similar Price/Free Cash Flow ratio as DIM.
Industry RankSector Rank
P/FCF 33.51
EV/EBITDA 25.93
DIM.PA Per share dataDIM.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as DIM's earnings are expected to grow with 23.30% in the coming years.
PEG (NY)1.5
PEG (5Y)9.87
EPS Next 2Y23.83%
EPS Next 3Y23.3%

More info and screens

3

5. Dividend

5.1 Amount

With a yearly dividend of 0.39%, DIM is not a good candidate for dividend investing.
DIM's Dividend Yield is slightly below the industry average, which is at 0.71.
Compared to an average S&P500 Dividend Yield of 2.32, DIM's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.39%

5.2 History

The dividend of DIM has a limited annual growth rate of 4.44%.
Dividend Growth(5Y)4.44%
Div Incr Years0
Div Non Decr Years1
DIM.PA Yearly Dividends per shareDIM.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1

5.3 Sustainability

29.77% of the earnings are spent on dividend by DIM. This is a low number and sustainable payout ratio.
DIM's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP29.77%
EPS Next 2Y23.83%
EPS Next 3Y23.3%
DIM.PA Yearly Income VS Free CF VS DividendDIM.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
DIM.PA Dividend Payout.DIM.PA Dividend Payout, showing the Payout Ratio.DIM.PA Dividend Payout.PayoutRetained Earnings

More info and screens

SARTORIUS STEDIM BIOTECH

EPA:DIM (9/4/2025, 7:00:00 PM)

170.95

-3.3 (-1.89%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)07-22 2025-07-22/bmo
Earnings (Next)10-16 2025-10-16
Inst Owners10.65%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap16.64B
Analysts81.11
Price Target238.92 (39.76%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.39%
Yearly Dividend0.71
Dividend Growth(5Y)4.44%
DP29.77%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.2%
Min EPS beat(2)10.22%
Max EPS beat(2)22.18%
EPS beat(4)3
Avg EPS beat(4)8.6%
Min EPS beat(4)-5.62%
Max EPS beat(4)22.18%
EPS beat(8)3
Avg EPS beat(8)-10.02%
EPS beat(12)3
Avg EPS beat(12)-13.27%
EPS beat(16)5
Avg EPS beat(16)-12.35%
Revenue beat(2)2
Avg Revenue beat(2)1.91%
Min Revenue beat(2)0.3%
Max Revenue beat(2)3.52%
Revenue beat(4)3
Avg Revenue beat(4)0.4%
Min Revenue beat(4)-5.11%
Max Revenue beat(4)3.52%
Revenue beat(8)5
Avg Revenue beat(8)-0.72%
Revenue beat(12)5
Avg Revenue beat(12)-1.47%
Revenue beat(16)8
Avg Revenue beat(16)12%
PT rev (1m)-1.42%
PT rev (3m)-3.82%
EPS NQ rev (1m)0%
EPS NQ rev (3m)3.26%
EPS NY rev (1m)2.93%
EPS NY rev (3m)2.93%
Revenue NQ rev (1m)0.05%
Revenue NQ rev (3m)-0.9%
Revenue NY rev (1m)-0.26%
Revenue NY rev (3m)0.56%
Valuation
Industry RankSector Rank
PE 41.39
Fwd PE 31.85
P/S 5.74
P/FCF 33.51
P/OCF 21.11
P/B 4.16
P/tB N/A
EV/EBITDA 25.93
EPS(TTM)4.13
EY2.42%
EPS(NY)5.37
Fwd EY3.14%
FCF(TTM)5.1
FCFY2.98%
OCF(TTM)8.1
OCFY4.74%
SpS29.76
BVpS41.13
TBVpS-4.66
PEG (NY)1.5
PEG (5Y)9.87
Profitability
Industry RankSector Rank
ROA 2.71%
ROE 5.63%
ROCE 5.78%
ROIC 4.6%
ROICexc 5.12%
ROICexgc 15.67%
OM 14.71%
PM (TTM) 7.78%
GM 44.63%
FCFM 17.14%
ROA(3y)7.81%
ROA(5y)9.13%
ROE(3y)17.3%
ROE(5y)20.06%
ROIC(3y)10.41%
ROIC(5y)14.57%
ROICexc(3y)10.84%
ROICexc(5y)15.37%
ROICexgc(3y)26.31%
ROICexgc(5y)36.49%
ROCE(3y)13.07%
ROCE(5y)18.3%
ROICexcg growth 3Y-36.77%
ROICexcg growth 5Y-16.49%
ROICexc growth 3Y-43.34%
ROICexc growth 5Y-25.09%
OM growth 3Y-22.38%
OM growth 5Y-9.98%
PM growth 3Y-24.01%
PM growth 5Y-17.3%
GM growth 3Y-6.9%
GM growth 5Y-3.53%
F-Score7
Asset Turnover0.35
Health
Industry RankSector Rank
Debt/Equity 0.71
Debt/FCF 5.98
Debt/EBITDA 3.84
Cap/Depr 93.43%
Cap/Sales 10.07%
Interest Coverage 2.82
Cash Conversion 106.77%
Profit Quality 220.28%
Current Ratio 1.91
Quick Ratio 1.18
Altman-Z 3.68
F-Score7
WACC8.46%
ROIC/WACC0.54
Cap/Depr(3y)182.98%
Cap/Depr(5y)186.68%
Cap/Sales(3y)13.87%
Cap/Sales(5y)12.23%
Profit Quality(3y)126.76%
Profit Quality(5y)109.63%
High Growth Momentum
Growth
EPS 1Y (TTM)25.91%
EPS 3Y-22.3%
EPS 5Y4.19%
EPS Q2Q%38.82%
EPS Next Y27.61%
EPS Next 2Y23.83%
EPS Next 3Y23.3%
EPS Next 5Y22.31%
Revenue 1Y (TTM)5.44%
Revenue growth 3Y-1.25%
Revenue growth 5Y14.05%
Sales Q2Q%5.46%
Revenue Next Year9.1%
Revenue Next 2Y9.69%
Revenue Next 3Y10.4%
Revenue Next 5Y10.52%
EBIT growth 1Y7.47%
EBIT growth 3Y-23.35%
EBIT growth 5Y2.67%
EBIT Next Year91.76%
EBIT Next 3Y37.04%
EBIT Next 5Y27.78%
FCF growth 1Y202.01%
FCF growth 3Y7.94%
FCF growth 5Y22.24%
OCF growth 1Y16.41%
OCF growth 3Y5.11%
OCF growth 5Y21.32%